BrainWatch is developing imaging agents for MRI scanning. These imaging agents are used as biomarkers for specific diseases, in particular Alzheimer's disease and breast cancer. BrainWatch's biomarkers will notbe radioactive and will aim to have lower procedure costs and better diagnostic accuracy.